Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Exercise and Olanzapine-samidorphan — Stella

Home/Schizophenia Disorder/Exercise and Olanzapine-samidorphan

View on ClinicalTrials.gov

Recruiting

Back to Schizophenia Disorder trials

Exercise and Olanzapine-samidorphan

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

New York State Psychiatric Institute, New York, New York

Key details

Phase

Post-approval study

Sponsor

New York State Psychiatric Institute

Enrollment target

~30 participants

Started

June 2025

Primary completion

April 2027

Age range

18 Years – 65 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.